-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Non-alcoholic fatty liver disease (NAFLD) is one of the most serious fatty liver disease, its incidence rising, it has gradually become a common chronic liver disease.
Non-alcoholic fatty liver disease (NAFLD) is one of the most serious fatty liver disease, its incidence rising, it has gradually become a common chronic liver disease.
This retrospective cohort study included non-obese individuals, and all participants participated in the annual health check-ups conducted in Tokyo, Japan from 2008 to 2018.
The results of the study showed that of the 27,064 non-obese participants (with a total of 142,699 person-years of follow-up time), 2,895 were diagnosed with NAFLD.
diagnosis
This study confirmed that short-term weight gain is an independent risk factor for non-obese men to develop NAFLD.
This study confirmed that short-term weight gain is an independent risk factor for non-obese men to develop NAFLD.
Original source:
Yamada, Gen.
lww.
com/ajg/Abstract/2021/04000/Impact_of_Body_Weight_Gain_on_the_Incidence_of.
26.
aspx" target="_blank" rel="noopener">Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals.
Leave a message here